Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001940156 | SCV002179590 | uncertain significance | Danon disease | 2022-03-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. Studies have shown that this variant alters LAMP2 gene expression (PMID: 10972294). This variant is also known as c.1097_1098delAA (p.Gln366Argfs*6). This variant has been observed in individual(s) with Danon disease (PMID: 10972294). This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 8 of the LAMP2 gene. It does not directly change the encoded amino acid sequence of the LAMP2 protein. It affects a nucleotide within the consensus splice site. |
OMIM | RCV001940156 | SCV000030880 | pathogenic | Danon disease | 2000-08-24 | no assertion criteria provided | literature only |